During a session at the this week’s World Stem Cell Summit in San Diego, an international research team described an “astonishing” experiment in which a mouse model of multiple sclerosis was able to virtually totally recover and move normally after being transplanted with human neural precursor cells (hNPC). The scientists were able to show almost full recovery in the mice up to six months later.
Recent Posts
- RNA-guided CRISPR system activates gene expression
- Leveraging the Full Potential of Regenerative Medicine Requires a Proactive Approach
- Implantable islet cells could control diabetes without insulin injections
- With FDA go ahead, a China biotech notches a first in cell therapy testing
- Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells
- New RNA injection could help hearts heal after heart attacks
